JAMA & ARCHIVES
Arch Fam Med
SEARCH
GO TO ADVANCED SEARCH
HOME  PAST ISSUES  TOPIC COLLECTIONS  CME  PHYSICIAN JOBS  CONTACT US  HELP
Institution: STANFORD Univ Med Center  | My Account | E-mail Alerts | Access Rights | Sign In
  Vol. 9 No. 1, January 2000 TABLE OF CONTENTS
  Archives
  •  Online Features
  Original Contribution
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (13)
 •Contact me when this article is cited
 Related Content
 •Related articles
 •Similar articles in this journal

Somatoform Symptoms and Treatment Nonadherence in Depressed Family Medicine Outpatients

Robert Keeley, MD; Marcia Smith, PhD; John Miller, MD

Arch Fam Med. 2000;9:46-54.

Objectives  To examine whether somatoform symptoms, specifically symptoms of conversion, somatization, and hypochondriasis, are associated with side-effect reporting and treatment nonadherence in depressed family medicine outpatients, and to measure whether symptoms improve with pharmacotherapy.

Design  Inception cohort study with 14-week follow-up.

Setting  Inner-city family medicine residency clinic.

Patients  Thirty-nine consecutive adults with major depressive disorder were asked to participate, and 30 consented.

Intervention  Antidepressants for 14 weeks.

Main Outcome Measures  The Personality Assessment Inventory (PAI) was administered before treatment. The PAI is a self-reported inventory compatible with the Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, designed to measure a broad range of personality characteristics. After 14 weeks, the side-effect incidence and treatment nonadherence rates were determined, and 12 patients were readministered the PAI.

Results  Depressed family medicine patients demonstrated trends toward elevated Somatic Complaints scale and conversion subscale scores and a lower Suicidal Ideation scale score relative to those of a standardized depressed psychiatric patient profile. Conversion and hypochondriacal symptoms were associated with side-effect reporting and treatment nonadherence. Somatization and hypochondriacal symptoms improved clinically and statistically during treatment for depression.

Conclusions  Somatoform distress is a complex, common, and understudied phenomenon in primary care that can adversely affect the treatment of depression. Somatoform symptoms of conversion and hypochondriasis, but not somatization, were found to be risk factors for treatment nonadherence. Somatization and hypochondriacal symptoms may represent personality states that improve with pharmacotherapy, and conversion symptoms may be a personality trait resistant to medical treatment for depression.


From the St Anthony Family Medicine Residency, St Anthony Central Hospital, Denver, Colo. Dr Keeley is now with the Salud Family Health Center, Longmont, Colo, and is a Clinical Instructor at the Department of Family Medicine, University of Colorado School of Medicine, Denver. Dr Smith is now with the Department of Family Medicine, Brown University, Providence, RI.


RELATED ARTICLES

Somatoform Symptoms and Treatment Nonadherence in Depressed Family Medicine Outpatients
Robert Keeley
Arch Fam Med. 2000;9(1):54.
FULL TEXT  

The Archives of Family Medicine Continuing Medical Education Program
Arch Fam Med. 2000;9(1):79-80.
FULL TEXT  


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Predictors of Premature Antidepressant Discontinuation in Functional Gastrointestinal Disorders
Sayuk et al.
Psychosom. Med. 2007;69:173-181.
ABSTRACT | FULL TEXT  

Effects of Duloxetine on Painful Physical Symptoms Associated With Depression
Goldstein et al.
Psychosomatics 2004;45:17-28.
ABSTRACT | FULL TEXT  

Impact of Pain on Depression Treatment Response in Primary Care
Bair et al.
Psychosom. Med. 2004;66:17-22.
ABSTRACT | FULL TEXT  

When Are Medication Side Effects Due to the Nocebo Phenomenon?
Palmer et al.
JAMA 2002;287:2502-2504.
FULL TEXT  

Is One Selective Serotonin Reuptake Inhibitor Better Than Another?
Elliott et al.
JAMA 2002;287:1935-1938.
FULL TEXT  

The Patient with Hypochondriasis
Barsky
NEJM 2001;345:1395-1399.
FULL TEXT  




HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | PHYSICIAN JOBS | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2000 American Medical Association. All Rights Reserved.